Article Details

Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine ...

Retrieved on: 2025-02-04 13:09:48

Tags for this article:

Click the tags to see associated articles and topics

Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine .... View article details on hiswai:

Excerpt

... Alopecia Areata . ... ALY-101 is an intradermal injectable JAK1 siRNA-lipid conjugate for the treatment of Alopecia Areata ...

Article found on: www.pharmiweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up